Cars.com
CARS
Lantheus
LNTH
Halozyme Therapeutics
HALO
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 25.21%244.38B | 28.66%65.72B | 28.02%62.77B | 24.40%60.48B | 19.28%55.42B | 8.42%195.19B | 11.63%51.08B | 8.48%49.03B | 7.10%48.61B | 6.36%46.46B |
Total premiums earned | 3.98%46B | 2.94%11.5B | 3.98%11.44B | 3.76%11.45B | 5.24%11.6B | 10.83%44.24B | 17.04%11.18B | 14.73%11B | 5.88%11.04B | 6.46%11.03B |
Net investment income | -9.88%73M | 383.85%2.21B | -372.47%-861M | -4.76%260M | 4.69%290M | 26.56%81M | 7.14%-780M | 67.20%316M | -9.30%273M | -33.09%277M |
Net realized gain loss on investments | -282.42%-1.84B | -280.41%-1.87B | 377.78%25M | -58.06%13M | -3,178.57%-1.84B | 66.72%1.01B | -2.08%1.04B | 86.57%-9M | 147.69%31M | 82.61%-56M |
Fee revenue and other income | 33.56%200.15B | 35.86%53.87B | 38.28%52.17B | 30.80%48.75B | 28.81%45.36B | 7.47%149.86B | 10.16%39.65B | 6.31%37.73B | 7.32%37.27B | 5.95%35.22B |
-Fees and commissions | 17.20%14.79B | 29.00%3.93B | 21.61%3.89B | 10.35%3.65B | 8.30%3.33B | 15.97%12.62B | 6.54%3.05B | 17.19%3.2B | 19.96%3.31B | 20.95%3.07B |
-Other income expense | 35.06%185.36B | 36.44%49.94B | 39.83%48.28B | 32.79%45.1B | 30.77%42.04B | 6.75%137.24B | 10.47%36.6B | 5.40%34.53B | 6.23%33.96B | 4.71%32.14B |
Total expenses | 26.07%239.12B | 25.18%63.71B | 30.48%61.58B | 25.16%58.49B | 23.36%55.34B | 10.51%189.67B | 14.62%50.89B | 13.15%47.19B | 7.65%46.73B | 6.51%44.86B |
Loss adjustment expense | 6.51%38.65B | 9.55%10.17B | 6.72%9.53B | 5.32%9.52B | 4.36%9.44B | 12.75%36.29B | 16.45%9.28B | 15.17%8.93B | 10.28%9.03B | 9.36%9.05B |
Selling general and administration | 0.15%14.84B | -4.85%3.87B | -5.23%3.59B | 7.28%3.68B | 4.72%3.71B | 12.51%14.82B | 16.59%4.06B | 20.22%3.79B | 5.21%3.43B | 8.03%3.54B |
Depreciation and amortization | -6.38%1.7B | -5.99%424M | -3.96%436M | -7.69%420M | -7.84%423M | -3.04%1.82B | -1.31%451M | -1.30%454M | -9.18%455M | 0.22%459M |
-Amortization | -6.38%1.7B | -5.99%424M | -3.96%436M | -7.69%420M | -7.84%423M | -3.04%1.82B | -1.31%451M | -1.30%454M | -9.18%455M | 0.22%459M |
Non-operating net interest income (expenses) | 0.76%-1.44B | -0.56%-362M | -3.01%-376M | -3.31%-375M | 10.06%-322M | -17.75%-1.45B | -11.11%-360M | -20.07%-365M | -20.60%-363M | -19.73%-358M |
-Interest expense-non operating | -0.76%1.44B | 0.56%362M | 3.01%376M | 3.31%375M | -10.06%322M | 17.75%1.45B | 11.11%360M | 20.07%365M | 20.60%363M | 19.73%358M |
Special income (charges) | 101.60%24M | 108.80%130M | -314.29%-87M | --0 | ---19M | -190.19%-1.5B | -1,924.66%-1.48B | -101.21%-21M | --0 | --0 |
-Less:Other special charges | -101.60%-24M | -108.80%-130M | 314.29%87M | ---- | --19M | 190.19%1.5B | 1,924.66%1.48B | 101.21%21M | ---- | ---- |
Income before tax | -4.43%5.27B | 968.62%2.01B | -35.22%1.19B | 5.57%1.99B | -95.07%79M | -34.35%5.51B | -86.16%188M | -47.29%1.84B | -4.90%1.88B | 2.17%1.6B |
Income tax | 957.45%1.49B | 151.47%473M | -6.14%367M | -3.74%360M | -1.36%291M | -91.27%141M | -775.74%-919M | -45.16%391M | -9.00%374M | -16.90%295M |
Earnings from equity interest net of tax | ||||||||||
Net income | -29.67%3.78B | 38.75%1.54B | -43.06%825M | 7.88%1.63B | -116.23%-212M | -20.79%5.37B | -9.41%1.11B | -47.84%1.45B | -3.82%1.51B | 7.76%1.31B |
Net Income continuous operations | -29.67%3.78B | 38.75%1.54B | -43.06%825M | 7.88%1.63B | -116.23%-212M | -20.79%5.37B | -9.41%1.11B | -47.84%1.45B | -3.82%1.51B | 7.76%1.31B |
Minority interest income | 65.38%344M | 43.59%112M | 109.76%86M | 62.00%81M | 66.67%65M | 166.67%208M | 168.97%78M | 95.24%41M | 284.62%50M | 160.00%39M |
Net income attributable to the parent company | -33.50%3.43B | 38.39%1.42B | -47.51%739M | 6.03%1.55B | -121.86%-277M | -22.97%5.16B | -13.75%1.03B | -48.93%1.41B | -6.23%1.46B | 5.85%1.27B |
Preferred stock dividends | ||||||||||
Other preferred stock dividend | ||||||||||
Net income attributable to common stockholders | -33.50%3.43B | 38.39%1.42B | -47.51%739M | 6.03%1.55B | -121.86%-277M | -22.97%5.16B | -13.75%1.03B | -48.93%1.41B | -6.23%1.46B | 5.85%1.27B |
Basic earnings per share | -30.28%12.25 | 46.99%5.13 | -44.68%2.65 | 11.09%5.51 | -122.66%-0.97 | -18.88%17.57 | -8.82%3.49 | -47.19%4.79 | 0.40%4.96 | 13.83%4.28 |
Diluted earnings per share | -30.30%12.12 | 46.99%5.13 | -44.51%2.63 | 10.77%5.45 | -122.88%-0.97 | -18.78%17.39 | -8.82%3.49 | -47.16%4.74 | 0.61%4.92 | 13.67%4.24 |
Dividend per share | 13.82%5.6 | 13.82%1.4 | 13.82%1.4 | 13.82%1.4 | 13.82%1.4 | 9.82%4.92 | 9.82%1.23 | 9.82%1.23 | 9.82%1.23 | 9.82%1.23 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |